BTK Inhibitors for Waldenström’s Macroglobulinemia: Comparisons, Benefits, and the Future
source: shutterstock.com

BTK Inhibitors for Waldenström’s Macroglobulinemia: Comparisons, Benefits, and the Future

According to a story from AJMC, a recent critical review evaluated the class of therapies known as Bruton tyrosine kinase (BTK) inhibitors and their use in the treatment of Waldenström's…

Continue Reading BTK Inhibitors for Waldenström’s Macroglobulinemia: Comparisons, Benefits, and the Future
Primary Hyperoxaluria Drug’s Label Receives Expansion to Include Patients with More Severe Disease
source: pixabay.com

Primary Hyperoxaluria Drug’s Label Receives Expansion to Include Patients with More Severe Disease

According to a press release published on globalgenes.org, the US Food and Drug Administration (FDA) has expanded the label for Oxlumo, a drug developed by Alnylam Pharmaceuticals as a treatment…

Continue Reading Primary Hyperoxaluria Drug’s Label Receives Expansion to Include Patients with More Severe Disease
Enrollment Completed for Phase 3 Pyruvate Dehydrogenase Complex Deficiency (PDCD) Clinical Trial
source: unsplash.com

Enrollment Completed for Phase 3 Pyruvate Dehydrogenase Complex Deficiency (PDCD) Clinical Trial

According to a story from PR Newswire, the pharmaceutical company Saol Therapeutics has recently announced that it has completed its enrollment goals for its phase 3 clinical trial. This trial…

Continue Reading Enrollment Completed for Phase 3 Pyruvate Dehydrogenase Complex Deficiency (PDCD) Clinical Trial
The Power of Our Inner Dialogue on Our Health
https://pixabay.com/en/peace-of-mind-woman-girl-outdoors-349815/

The Power of Our Inner Dialogue on Our Health

I believe very strongly in the power of thoughts and words as it relates to my health. I say this because I have lived with a painful chronic neurological movement…

Continue Reading The Power of Our Inner Dialogue on Our Health
In Utero DMD Therapy Was Unsuccessful in Murine Models
Alexas_Fotos / Pixabay

In Utero DMD Therapy Was Unsuccessful in Murine Models

The current standards-of-care for those with Duchenne muscular dystrophy (DMD) include corticosteroids, immunosuppressive treatments, physical therapy, and occupational therapy (among others). Gene therapy has the potential to change the treatment…

Continue Reading In Utero DMD Therapy Was Unsuccessful in Murine Models
Researchers Discover a Method to Cross the Blood-Brain Barrier and Treat Lethal Tumors
source: pixabay.com

Researchers Discover a Method to Cross the Blood-Brain Barrier and Treat Lethal Tumors

  Researchers at Brown University, in collaboration with an MIT research team, discovered a method of penetrating the blood-brain barrier (BBB) in mice and delivering medication to treat lethal tumors…

Continue Reading Researchers Discover a Method to Cross the Blood-Brain Barrier and Treat Lethal Tumors